HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY OF IODODOXORUBICIN AND FLUORESCENT METABOLITES IN PLASMA SAMPLES

被引：9

作者：

MROSS, K

MAYER, U

HAMM, K

HOSSFELD, DK

机构：

[1] Department of Oncology/Hematology, University Clinic Eppendorf, D-2000 Hamburg 20

来源：

JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS | 1990年 / 530卷 / 01期

关键词：

D O I：

10.1016/S0378-4347(00)82321-X

中图分类号：

O65 [分析化学];

学科分类号：

070302 ; 081704 ;

摘要：

[No abstract available]

引用

页码：192 / 199

页数：8

共 11 条

[1]

FANCHINETTI T, 1986, DRUGS EXP CLIN RES, V12, P657

[2]

FORMELLI F, 1987, CANCER RES, V47, P5401

[3]

LEITNER SP, 1985, CANCER TREAT REP, V69, P1319

[4] IMPROVED METHOD FOR THE DETERMINATION OF 4'-EPIDOXORUBICIN AND 7 METABOLITES IN PLASMA BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY [J].

MAESSEN, PA ;

MROSS, KB ;

PINEDO, HM ;

VANDERVIJGH, WJF .

JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1987, 417 (02) :339-346

[5] PHARMACOKINETICS AND METABOLISM OF EPIDOXORUBICIN AND DOXORUBICIN IN HUMANS [J].

MROSS, K ;

MAESSEN, P ;

VANDERVIJGH, WJF ;

GALL, H ;

BOVEN, E ;

PINEDO, HM .

JOURNAL OF CLINICAL ONCOLOGY, 1988, 6 (03) :517-526

[6]

MROSS K, 1990, IN PRESS EUR J CLIN

[7] REDUCTION BY THE GUT MICROFLORA OF ANIMALS AND MAN [J].

ROWLAND, IR .

BIOCHEMICAL PHARMACOLOGY, 1986, 35 (01) :27-32

[8] CONGESTIVE-HEART-FAILURE AND LEFT-VENTRICULAR DYSFUNCTION COMPLICATING DOXORUBICIN THERAPY - 7-YEAR EXPERIENCE USING SERIAL RADIONUCLIDE ANGIOCARDIOGRAPHY [J].

SCHWARTZ, RG ;

MCKENZIE, WB ;

ALEXANDER, J ;

SAGER, P ;

DSOUZA, A ;

MANATUNGA, A ;

SCHWARTZ, PE ;

BERGER, HJ ;

SETARO, J ;

SURKIN, L ;

WACKERS, FJT ;

ZARET, BL .

AMERICAN JOURNAL OF MEDICINE, 1987, 82 (06) :1109-1118

[9]

SUPINO R, 1988, CANCER CHEMOTH PHARM, V21, P251

[10]

VILLANI F, 1987, PROCESS ANTIMICROBIA, V3, P747

← 1 2 →